The first two episodes will air on Aug. 26, a few days before jury selection begins.
“It’s the last chapter of a saga that began six years ago, the final chapter I couldn’t write… And it promises to be fascinating,” he wrote on Twitter.
Carreyrou won two Pulitzer Prizes but left the newspaper in 2019 over its paid speaking ban for journalists. The Reporters Committee for Freedom of the Press honored Carreyrou with a Freedom of the Press Award for his reporting on the Theranos scandal.
Theranos’s lawyers also used threats of litigation against Carreyrou and The Journal in attempts to have the story killed.
“Bad Blood” won the Business Book of the Year in 2018. He also won the Polk Award for financial reporting for his Theranos coverage.
His investigation of Theranos Inc. raised serious doubts about claims by the firm and its celebrated 31-year-old founder, Holmes, that its new procedure for drawing and testing blood was a transformational medical breakthrough in wide use at the firm’s labs.
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…